Constellation Pharmaceuticals is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Constellation Pharmaceuticals's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Constellation Pharmaceuticals or its management. Constellation Pharmaceuticals does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.

http://ir.constellationpharma.com/financial-information/analyst-coverage

Do RVX and Zenith pass any sniff test when it comes to analyst coverage? This seriously needs to be addressed! What was IR doing over the last few months? Who have they talked to? My brokerage account info keeps showing only one analyst for Resverlogix. So, in their eyes, paying for coverage doesn't count.

We all need these two companies to start performing, but unless something really positive gets announced in the next few weeks, I'm really concerned that September will be yet another nail-biter filled with a lot of unnecessary drama - or even worse!